Using Vedolizumab-800CW to Gain Insight Into Local Drug Distribution and Mucosal Target Cells in IBD Patients
Clinical trial NCT04112212 · COMPLETED
Trial details
- NCT number
- NCT04112212
- Sponsor
- University Medical Center Groningen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-04
- Primary completion
- 2022-10-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.